Collegium Pharmaceutical Inc
COLL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$788.17M
Close$
$17.40
29.9% downside
Current Fair Value
29.9% downsideOvervalued by 29.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $788.17 Million |
|---|---|
| Enterprise Value | $1.73 Billion |
| Earnings per Share | $1.98 |
| Beta | 0.73 |
| Outstanding Shares | 31,731,198 |
Return
| Return on Equity | 12.88% |
|---|---|
| Return on Assets | 1.82% |
| Return on Invested Capital | 13.51% |
Valuation & Multiples
| P/E Ratio | 19.84 |
|---|---|
| PEG | -64.14 |
| Price to Sales | 0.99 |
| Price to Book Ratio | 2.76 |
| Enterprise Value to Revenue | 2.12 |
| Enterprise Value to EBIT | 8.59 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | 3.67 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS
$1.96
Est. $1.86Revenue
$216.34 M
Est. $216.03 MNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
$1.93
Consensus analyst estimateRevenue Estimate
$222.21 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 190.76% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.08%▼ 107.44% |
|---|---|
| Total Invested | $113.94M▼ 92.06% |
| Investors Holding | 89▼ 195.00% |
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni
